Man Receives First In Vivo Gene-Editing Therapy (NOT CRISPR)

The 44-year-old patient has Hunter syndrome, which doctors hope to treat using zinc finger nucleases.

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website,

View all posts by Robert Zinn →